\-\ Texto\\:\\ \ \(0\)\
\-\ tsh\\ \\.005\\ \\ ft4\\ 4\\.6\ \(0\)\
\-\ cachetic\\ elderly\\ male\\ with\\ non\\ tender\\ \\,\\ nodular\\ thyroid\ \(0\)\
\-\ patient\\ treated\\ with\\ methimazole\\ \\-\\ mechanism\\ \\:\\ decreases\\ thyroid\\ hormone\\ production\\ \\-\\ inhibits\\ iodine\\ and\\ peroxidase\\ from\\ their\\ normal\\ interactions\\ with\\ thyroglobulin\\ to\\ form\\ t4\\ and\\ t3\\;\\ also\\ interferes\\ with\\ the\\ conversion\\ of\\ t4\\ to\\ t3\\.\ \(0\)\
\-\ thyroid\\ uptake\\ and\\ scan\\ with\\ i\\-131\\ 7\\.00\\ uci\\ po\\ and\\ \\ \\ \ \(0\)\
\-\ 99mtco4\\ 10\\.00\\ mci\\ iv\\ shows\\ mutliple\\ foci\\ of\\ increased\\ and\\ decreased\\ radiotracer\\ uptake\\ on\\ the\\ scan\\.\\ the\\ uptake\\ is\\ 45\\.8\\%\ \(0\)\
\-\ ultrasound\\ images\\ show\\ multiple\\ rather\\ well\\ circumscribed\\ foci\\ of\\ decreased\\ echogenicity\\.\ \(0\)\
\-\ toxic\\ multinodular\\ goiter\ \(1\)\
\-\ multinodular\\ goiter\ \(13\)\
\-\ 80\\ year\\ old\\ male\\ presents\\ with\\ fifty\\ pound\\ weight\\ loss\\ and\\ atrial\\ fibrillation\ \(1\)\
\-\ this\\ patient\\ initially\\ was\\ diagnosed\\ with\\ toxic\\ multinodular\\ goiter\\ in\\ 2004\\.\\ his\\ treatment\\ was\\ with\\ tapazole\\ as\\ described\\ above\\.\\ he\\ fogot\\ to\\ take\\ his\\ medication\\ for\\ a\\ few\\ weeks\\ and\\ was\\ readmitted\\ to\\ the\\ hospital\\ for\\ syncope\\/atrial\\ fibrillation\\.\\ the\\ second\\ scan\\ you\\ with\\ only\\ 13\\.2\\ percent\\ uptake\\ is\\ secondary\\ to\\ his\\ being\\ restarted\\ on\\ tapazole\\ two\\ days\\ before\\ the\\ scan\\,\\ thus\\ giving\\ a\\ fictitious\\ result\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ multinodular\\:\\ 0\\.09960873134714368\ \(0\)\
\-\ tapazole\\:\\ 0\\.0968738288347967\ \(0\)\
\-\ goiter\\:\\ 0\\.08980586693373666\ \(0\)\
\-\ uptake\\:\\ 0\\.07461502032294973\ \(0\)\
\-\ t3\\:\\ 0\\.06065584129628758\ \(0\)\
\-\ fibrillation\\:\\ 0\\.059498033431915856\ \(0\)\
\-\ thyroid\\:\\ 0\\.05773042491634139\ \(0\)\
\-\ t4\\:\\ 0\\.05504237290325471\ \(0\)\
\-\ toxic\\:\\ 0\\.05504237290325471\ \(0\)\
\-\ scan\\:\\ 0\\.05257739473479074\ \(0\)\
\-\ \\.005\\:\\ 0\\.04843691441739835\ \(0\)\
\-\ cachetic\\:\\ 0\\.04843691441739835\ \(0\)\
\-\ 7\\.00\\:\\ 0\\.04843691441739835\ \(0\)\
\-\ 99mtco4\\:\\ 0\\.04843691441739835\ \(0\)\
\-\ 10\\.00\\:\\ 0\\.04843691441739835\ \(0\)\
\-\ 45\\.8\\:\\ 0\\.04843691441739835\ \(0\)\
\-\ fogot\\:\\ 0\\.04843691441739835\ \(0\)\
\-\ syncope\\/atrial\\:\\ 0\\.04843691441739835\ \(0\)\
\-\ fictitious\\:\\ 0\\.04843691441739835\ \(0\)\
\-\ peroxidase\\:\\ 0\\.04462841342531074\ \(0\)\
\-\ interactions\\:\\ 0\\.04462841342531074\ \(0\)\
\-\ methimazole\\:\\ 0\\.040819912433223124\ \(0\)\
\-\ interferes\\:\\ 0\\.040819912433223124\ \(0\)\
\-\ his\\:\\ 0\\.04059707188429009\ \(0\)\
\-\ foci\\:\\ 0\\.04030795546322028\ \(0\)\
\-\ mutliple\\:\\ 0\\.039593848964463725\ \(0\)\
\-\ 13\\.2\\:\\ 0\\.039593848964463725\ \(0\)\
\-\ restarted\\:\\ 0\\.039593848964463725\ \(0\)\
\-\ inhibits\\:\\ 0\\.03774510041159992\ \(0\)\
\-\ fifty\\:\\ 0\\.03774510041159992\ \(0\)\
\-\ readmitted\\:\\ 0\\.03774510041159992\ \(0\)\
\-\ thyroglobulin\\:\\ 0\\.03701141144113551\ \(0\)\
\-\ 4\\.6\\:\\ 0\\.036364251904561974\ \(0\)\
\-\ uci\\:\\ 0\\.036364251904561974\ \(0\)\
\-\ pound\\:\\ 0\\.03578534797237611\ \(0\)\
\-\ conversion\\:\\ 0\\.035261665665758946\ \(0\)\
\-\ 2004\\.\\:\\ 0\\.03434378607969759\ \(0\)\
\-\ i\\-131\\:\\ 0\\.03255575091247436\ \(0\)\
\-\ ft4\\:\\ 0\\.0319768469802885\ \(0\)\
\-\ decreases\\:\\ 0\\.0319768469802885\ \(0\)\
\-\ giving\\:\\ 0\\.030750783511529108\ \(0\)\
\-\ mci\\:\\ 0\\.03053528508760998\ \(0\)\
\-\ iodine\\:\\ 0\\.029568852854293146\ \(0\)\
\-\ production\\:\\ 0\\.028450177276044576\ \(0\)\
\-\ decreased\\:\\ 0\\.027920400029940215\ \(0\)\
\-\ elderly\\:\\ 0\\.02764466368158372\ \(0\)\
\-\ you\\:\\ 0\\.027166579192629714\ \(0\)\
\-\ take\\:\\ 0\\.026942282519441495\ \(0\)\
\-\ po\\:\\ 0\\.02683347687495699\ \(0\)\
\-\ hormone\\:\\ 0\\.02662212368359548\ \(0\)\
\-\ percent\\:\\ 0\\.025585908464872673\ \(0\)\
\-\ tsh\\:\\ 0\\.025500720626762972\ \(0\)\
\-\ echogenicity\\:\\ 0\\.025252806147199953\ \(0\)\
\-\ mechanism\\:\\ 0\\.024157570418515937\ \(0\)\
\-\ atrial\\:\\ 0\\.02402674267844056\ \(0\)\
\-\ medication\\:\\ 0\\.02365197207389917\ \(0\)\
\-\ thus\\:\\ 0\\.0233580782005421\ \(0\)\
\-\ rather\\:\\ 0\\.022318286993737002\ \(0\)\
\-\ 80\\:\\ 0\\.022086416914119545\ \(0\)\
\-\ form\\:\\ 0\\.02195185087011792\ \(0\)\
\-\ radiotracer\\:\\ 0\\.021907718058594493\ \(0\)\
\-\ few\\:\\ 0\\.021130247936211526\ \(0\)\
\-\ circumscribed\\:\\ 0\\.02086944278654711\ \(0\)\
\-\ their\\:\\ 0\\.020551344004025668\ \(0\)\
\-\ \\-\\:\\ 0\\.02012888416163037\ \(0\)\
\-\ described\\:\\ 0\\.01999653127138829\ \(0\)\
\-\ before\\:\\ 0\\.019873743915937762\ \(0\)\
\-\ nodular\\:\\ 0\\.019694559379735778\ \(0\)\
\-\ non\\:\\ 0\\.01940832250125555\ \(0\)\
\-\ initially\\:\\ 0\\.019109782111347146\ \(0\)\
\-\ tender\\:\\ 0\\.019057202710159503\ \(0\)\
\-\ second\\:\\ 0\\.018033675468346035\ \(0\)\
\-\ result\\:\\ 0\\.01801200086235144\ \(0\)\
\-\ hospital\\:\\ 0\\.01767635420312156\ \(0\)\
\-\ diagnosed\\:\\ 0\\.017264808553818713\ \(0\)\
\-\ above\\:\\ 0\\.017208454157295695\ \(0\)\
\-\ iv\\:\\ 0\\.017134202953082933\ \(0\)\
\-\ male\\:\\ 0\\.01698028063612608\ \(0\)\
\-\ weight\\:\\ 0\\.01682937244582893\ \(0\)\
\-\ being\\:\\ 0\\.01636147240000307\ \(0\)\
\-\ was\\:\\ 0\\.016290288827698136\ \(0\)\
\-\ show\\:\\ 0\\.014412944695008935\ \(0\)\
\-\ days\\:\\ 0\\.014390518110835042\ \(0\)\
\-\ only\\:\\ 0\\.014117646475191955\ \(0\)\
\-\ treated\\:\\ 0\\.014054125472988238\ \(0\)\
\-\ ultrasound\\:\\ 0\\.013929244972562108\ \(0\)\
\-\ loss\\:\\ 0\\.013628924024551866\ \(0\)\
\-\ two\\:\\ 0\\.013446874931956076\ \(0\)\
\-\ weeks\\:\\ 0\\.013325701960995322\ \(0\)\
\-\ secondary\\:\\ 0\\.013126538277520921\ \(0\)\
\-\ he\\:\\ 0\\.013099930450730877\ \(0\)\
\-\ shows\\:\\ 0\\.012908646701807027\ \(0\)\
\-\ to\\:\\ 0\\.011732640341840283\ \(0\)\
\-\ increased\\:\\ 0\\.011486180119778328\ \(0\)\
\-\ \\;\\:\\ 0\\.011128687848640625\ \(0\)\
\-\ \\%\\:\\ 0\\.01095231337003301\ \(0\)\
\-\ well\\:\\ 0\\.01062132391741017\ \(0\)\
\-\ multiple\\:\\ 0\\.009889043975160819\ \(0\)\
\-\ presents\\:\\ 0\\.009591452173120473\ \(0\)\
\-\ treatment\\:\\ 0\\.009503389887916963\ \(0\)\
\-\ patient\\:\\ 0\\.00941309814193833\ \(0\)\
\-\ also\\:\\ 0\\.009256151613572261\ \(0\)\
\-\ images\\:\\ 0\\.009006944461260187\ \(0\)\
\-\ for\\:\\ 0\\.008012177457612254\ \(0\)\
\-\ on\\:\\ 0\\.00795484628972998\ \(0\)\
\-\ normal\\:\\ 0\\.0073605079923027535\ \(0\)\
\-\ as\\:\\ 0\\.007102074208209494\ \(0\)\
\-\ from\\:\\ 0\\.0069584379843638045\ \(0\)\
\-\ and\\:\\ 0\\.006923423297393018\ \(0\)\
\-\ \\:\\:\\ 0\\.006210301186761896\ \(0\)\
\-\ is\\:\\ 0\\.006179019542689293\ \(0\)\
\-\ with\\:\\ 0\\.005785920795653888\ \(0\)\
\-\ this\\:\\ 0\\.005280973699528204\ \(0\)\
\-\ year\\:\\ 0\\.005253325655345685\ \(0\)\
\-\ old\\:\\ 0\\.004807332949792608\ \(0\)\
\-\ the\\:\\ 0\\.004557668726493158\ \(0\)\
\-\ a\\:\\ 0\\.00435823958042419\ \(0\)\
\-\ \\,\\:\\ 0\\.002974835884805356\ \(0\)\
\-\ in\\:\\ 0\\.0023153693963750273\ \(0\)\
\-\ of\\:\\ 0\\.0019203923208459632\ \(0\)\
\-\ \\.\\:\\ 0\\.0011703143768355916\ \(0\)\
